Latest filing published 13 Mar 2023 for Raphael Pharmaceutical Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Guy Ofir: trading record in brief
Guy Ofir discloses dealings in Raphael Pharmaceutical Inc. to SEC (Form 4). Between 26 September 2008 and 26 July 2022, the trades on record add up to 22 filings.
No open-market sale appears; the market trades are 21 purchases worth €167k. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.
The median purchase comes to €1,724.
The record was last updated on 13 March 2023 with a share grant in Raphael Pharmaceutical Inc. The last purchase on record was published on 22 September 2009, which is 6,256 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Guy Ofir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares0Common StockSEC:0001213900-23-019553:0
- 404,153 shares@ US$0.095Common StockSEC:0001165527-09-000698:0Canonical exit: 2 Dec 2009 (T+90)
- 1,000,000 shares@ US$0.15Common StockSEC:0001165527-09-000698:1Canonical exit: 21 Dec 2009 (T+90)
- 100,000 shares@ US$0.06Common StockSEC:0001165527-08-000751:0Canonical exit: 2 Mar 2009 (T+90)
- 100,000 shares@ US$0.065Common StockSEC:0001165527-08-000751:1Canonical exit: 2 Mar 2009 (T+90)
- 5,000 shares@ US$0.15Common StockSEC:0001165527-08-000735:0Canonical exit: 31 Dec 2008 (T+90)
- 5,000 shares@ US$0.14Common StockSEC:0001165527-08-000735:1Canonical exit: 1 Jan 2009 (T+90)
- 29,800 shares@ US$0.15Common StockSEC:0001165527-08-000735:2Canonical exit: 1 Jan 2009 (T+90)
- 45,000 shares@ US$0.15Common StockSEC:0001165527-08-000736:0Canonical exit: 2 Feb 2009 (T+90)
- 10,000 shares@ US$0.16Common StockSEC:0001165527-08-000736:1Canonical exit: 2 Feb 2009 (T+90)
- 50,000 shares@ US$0.10Common StockSEC:0001165527-08-000736:2Canonical exit: 10 Feb 2009 (T+90)
- 15,000 shares@ US$0.08Common StockSEC:0001165527-08-000736:3Canonical exit: 22 Feb 2009 (T+90)
- 15,000 shares@ US$0.07Common StockSEC:0001165527-08-000736:4Canonical exit: 22 Feb 2009 (T+90)
- 20,000 shares@ US$0.09Common StockSEC:0001165527-08-000736:6Canonical exit: 22 Feb 2009 (T+90)
- 5,000 shares@ US$0.14Common StockSEC:0001165527-08-000572:0Canonical exit: 29 Dec 2008 (T+90)
- 38,500 shares@ US$0.15Common StockSEC:0001165527-08-000572:1Canonical exit: 29 Dec 2008 (T+90)
- 20,000 shares@ US$0.15Common StockSEC:0001165527-08-000557:0Canonical exit: 25 Dec 2008 (T+90)
- 5,000 shares@ US$0.15Common StockSEC:0001165527-08-000557:1Canonical exit: 28 Dec 2008 (T+90)
- 00Common StockSEC:0001165527-08-000557:2Canonical exit: 28 Dec 2008 (T+90)
19 of 19 declarations